News & Events

You are here

See Top 10 CRO article here

Asia-Pacific specialist CRO Novotech has been selected as one of the Top 10 CROs globally by leading industry media magazine Pharma Tech Outlook.

03/10/17

Novotech Update: EMA releases addendum to ICH Guidelines, highlighting importance of considering treatment effects when planning clinical trials

The European Medicines Agency (EMA) recently released an addendum regarding International Conference for Harmonisation’s Guidelines on statistical principles for clinical trials (ICH E9) – with the addendum highlighting the importance of...

29/09/17

Outsourcing Clinical Trial South California 2017: Regulatory change is increasing Asia’s attractiveness as a clinical trial destination

At this year’s Outsourcing Clinical Trial South California 2017, Novotech Director Mr Barry Murphy presented an overview of recent regulatory changes in Asia, highlighting the resulting unique clinical trial benefits available within the region,...

20/09/17

Accelerating Clinical Trials in Asia 2017: Changes to Asia’s regulatory environment increasing its attractiveness as a clinical trial destination

Presenting at this year’s Accelerating Clinical Trials in Asia 2017, Novotech CRO Executive Director Dr Yooni Kim presented an overview of recent regulatory change in Asia and discussed its resulting impact on clinical trial management and...

30/08/17

Novotech Update: Three clinical trial and regulatory updates you need to know for your next clinical trial

FDA agrees to IRB Waivers for Minimal Risk Studies 
The FDA recently issued new guidance ...

24/08/17

ARCS 2017: Australia plays a key role in bringing clinical research to Asia, says Novotech

During a panel discussion at this year’s ARCS 2017, Novotech CEO Dr John Moller discussed Australia’s role as a clinical trials gateway into Asia and the important role Australia can play in growing this regional opportunity. 

“Asia is an...

20/08/17

Novotech Update: Novotech shares the importance of good clinical trial project management with Taiwanese biotech companies

Novotech recently delivered an educational workshop on the importance of ‘Timeline Management and Project Tracking’ at an event held by Taiwan’s Development Centre of Biotechnology

Novotech...

18/08/17

NZACRes 2017: Novotech outlines opportunities for New Zealand to increase clinical trial competitiveness

Presenting at NZACRes 2017, Novotech warned New Zealand must continue to invest in areas where it has existing advantages or structural potential, if it is to continue to maintain its leading research position.

...

10/08/17

CentreWatch Weekly covers Novotech's rapid growth in South Korea

In a front page article, leading US clinical trials CentreWatch Weekly magazine interviews Novotech CEO Dr John Moller on the company's rapid growth in South Korea. 

31/07/17

노보텍, 세브란스 병원 및 SCI-Consortium 과 업무 협약 체결

 노보텍, 세브란스 병원 및 SCI-Consortium 과 업무 협약 체결

2017년 7월 31일, 호주 시드니, 대한민국 서울:

아시아태평양 전문 임상시험수탁기관(CRO) 노보텍은 세브란스병원 및 SCI-...

31/07/17

Novotech signs MOU with South Korea’s SCI-Consortium and Severance Hospital

31 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea’s SCI-Consortium of Clinical Trial Centers...

Pages